CDC Shuts Down Army Lab’s Disease Research

The agency cites lapses in biosafety procedures at the US Army Medical Research Institute of Infectious Diseases in Maryland.

| 2 min read
a biosafety suit hanging in a hallway

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: FLICKR, MARYLAND GOVPICS

Research on dangerous pathogens has been suspended at an Army lab at Fort Detrick in Maryland after the Centers for Disease Control and Prevention found biosafety lapses there, the Frederick News-Post reported August 2. A spokesperson for the US Army Medical Research Institute of Infectious Diseases (USAMRIID) tells the newspaper that no disease-causing materials have been found outside authorized areas at the site.

According to its website, USAMRIID has been the US Department of Defense’s lead laboratory for medical biological defense research since 1969. The News-Post reports that the facility has both level 3 and level 4 biosafety labs and has worked on pathogens such as Ebola, Yersinia pestis (plague), and Francisella tularensis (tularemia). Those pathogens are among those considered “select agents and toxins” by the Department of Health and Human Services, which only allows authorized labs to work on them.

The New York Times, quoting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Shawna Williams

    Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor's degree in biochemistry from Colorado College and a graduate certificate and science communication from the University of California, Santa Cruz.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio